Medical devices
search
news
Pictures from NO therapy of diabetic foot by PLASON device 
The PDF with the short report with pictures from the therapy of a diabetic foot can be viewed or downloaded here.
The pictures from the treatment of unhealing wounds an be found here:
http://www.onkocet.eu/en/produkty-detail/220/1/
The pictures from the treatment of unhealing wounds an be found here:
http://www.onkocet.eu/en/produkty-detail/293/1/
The PDF with the short report with pictures from the therapy of a diabetic foot can be viewed or downloaded here.
The pictures from the treatment of unhealing wounds an be found here:
http://www.onkocet.eu/en/produkty-detail/220/1/
The pictures from the treatment of unhealing wounds an be found here:
http://www.onkocet.eu/en/produkty-detail/293/1/
12.5.2011 12:23
We have exhibited our devices on the prestigious MEDTEC UK exhibition in Birmingham
ONKOCET Ltd. has exhibited the devices from its portfolio on the MEDTEC UK exhibition in Birmingham, April 2011 through our partner Medical & Partners.
12.4.2011 12:27
Certification of SVIT infrared camera completed
The ONKOCET company has successfully reached the certification of yet another medical device, Infrared Camera SVIT. The Certificate can be found here. The videos from the device operation can be found here.
The ONKOCET company has successfully reached the certification of yet another medical device, Infrared Camera SVIT. The Certificate can be found here. The videos from the device operation can be found here. 4.3.2011 11:38
Golden Incheba prize for AMP device
Our device, the non-invasive blood analyzer AMP has won the Golden Incheba prize at a medical exhibition SLOVMEDICA - NON-HANDICAP 2010. A big thank you goes to the organizers of the exhibition for acknowledging the quality of our device and to the exhibitor, the Medical & Partners company, for introduction of the AMP device to the medical public again.
Our device, the non-invasive blood analyzer AMP has won the Golden Incheba prize at a medical exhibition SLOVMEDICA - NON-HANDICAP 2010. A big thank you goes to the organizers of the exhibition for acknowledging the quality of our device and to the exhibitor, the Medical & Partners company, for introduction of the AMP device to the medical public again. 4.10.2010 11:29
Certification of Concor Soft Contact Lenses successfully finished.
We are pleased to inform our business partners, that our company has succesfully finished the certification process of Concor Soft Contact Lenses.
You can find the certificate here.
More information on Concor Soft Contact Lenses go to section Medical preparations/Concor soft contact lenses, or follow this link.
We are pleased to inform our business partners, that our company has succesfully finished the certification process of Concor Soft Contact Lenses.
You can find the certificate here.More information on Concor Soft Contact Lenses go to section Medical preparations/Concor soft contact lenses, or follow this link.
16.6.2010 11:51
Certification of MAS-1K Spirometer successfully finished.
Our company has finished the certification process for another medical device, computerized spirometer MAS-1K with oximeter. You can find the device certificate here.
Our company has finished the certification process for another medical device, computerized spirometer MAS-1K with oximeter. You can find the device certificate here. 2.6.2010 10:58
New version of AMP device available
.jpg)
Since May 2010 there is a new version of AMP device available.
Follow this link if you want to see the pictures and specifications of the device.
Since May 2010 there is a new version of AMP device available.Follow this link if you want to see the pictures and specifications of the device.
11.5.2010 15:17
Treatment of burns with PLASON We added photographs of treatment of burns with PLASON device:
http://www.onkocet.eu/en/produkty-detail/293/1/
http://www.onkocet.eu/en/produkty-detail/293/1/
17.3.2010 12:08
Certification of PLASON device finished, CE issued.
Dear partners,
In October 2009 we have received CE certificate for another device from our portfolio, NO therapeutical device PLASON. You can find more information about this revolutionary device, used for healing of unhealing wounds, diabetic foot, or for cosmetical purposes, at our webpage, section "Medical devices" -> PLASON-NO Therapy.
.gif)
Best regards
Team of ONKOCET Ltd. company
Dear partners, In October 2009 we have received CE certificate for another device from our portfolio, NO therapeutical device PLASON. You can find more information about this revolutionary device, used for healing of unhealing wounds, diabetic foot, or for cosmetical purposes, at our webpage, section "Medical devices" -> PLASON-NO Therapy.
Best regards
Team of ONKOCET Ltd. company
23.1.2009 15:30
Breast thermography
Breast Thermography
In 1982, the FDA approved breast thermography as an adjunctive breast cancerscreening procedure.• Breast thermography has undergone extensive research since the late 1950's.
• Over 30 years of research comprising over 800 peer-reviewed studies on breastthermography exist in the index-medicus literature.
• In this database, over 300,000 women have been included as study participants.
• The numbers of participants in many studies are very large -- 10K, 37K, 60K, 85K …
• Some of these studies have followed patients up to 12 years.
• Strict standardized interpretation protocols have been established for over 15 years.
• Breast thermography has an average sensitivity and specificity of 90%.
• An abnormal thermogram is 10 times more significant as a future risk indicator forbreast cancer than a first order family history of the disease.
• A persistent abnormal thermogram carries with it a 22x higher risk of future breastcancer.
• An abnormal infrared image is the single most important marker of high risk fordeveloping breast cancer.
• Breast thermography has the ability to detect the first signs that a cancer may beforming up to 10 years before any other procedure can detect it.
• Research has shown that breast thermography significantly augments the long-termsurvival rates of its recipients by as much as 61%.
• When used as part of a multimodal approach (clinical examination + mammography+ thermography) 95% of early stage cancers will be detected.
Dr. William Amalu and al./ Medical Devices and Systems/ The Biomedical Engineering Handbook; Third Edition, 2006